Dopamine D1 and D2 receptors mediate analgesic and hypnotic effects of l-tetrahydropalmatine in a mouse neuropathic pain model
Levo-tetrahydropalmatine (l-THP), an active ingredient of Corydalis yanhusuo, has been reported to be a partial agonist for dopamine D1 receptors (D1R) and an antagonist for D2R. Although it has been safely used clinically in China for decades as an analgesic with sedative/hypnotic properties, there are few studies that address the mechanisms by which l-THP exerts its beneficial effects in chronic pain-induced sleep disturbance.
To investigate the effects and mechanisms of l-THP on sleep disturbance in a neuropathic pain-like condition.
A mouse model of chronic neuropathic pain induced by partial sciatic nerve ligation (PSNL) was employed. The antinociceptive and hypnotic effects of l-THP were evaluated by measurement of mechanical allodynia, thermal hyperalgesia, and electroencephalogram (EEG) recordings in PSNL mice. Pharmacological approaches and c-Fos expression were used to clarify the mechanisms of l-THP.
Intraperitoneal injection of l-THP at 5 and 10 mg/kg not only significantly increased the mechanical threshold by 134.4% and 174.8%, and prolonged the thermal latency by 49.4% and 69.2%, but also increased non-rapid eye movement sleep by 17.5% and 29.6%, and decreased sleep fragmentation in PSNL mice, compared with the vehicle control. Moreover, the antinociceptive effect of l-THP was prevented by D1R antagonist SCH23390 or D2R agonist quinpirole; meanwhile, the hypnotic effect of l-THP was blocked by quinpirole rather than by SCH23390. Immunohistochemistry demonstrated that l-THP inhibited c-Fos overexpression induced by PSNL in the cingulate cortex and the periaqueductal gray.
These findings indicated that l-THP exerted analgesic effects by agonism D1R and antagonism D2R, and the antagonism of D2R mediated the hypnotic effect of l-THP in PSNL mice.
KeywordsLevo-tetrahydropalmatine Sleep disturbance Neuropathic pain Dopamine receptor c-Fos
This manuscript is dedicated to the late Dr.Guo-Zhang Jin to acknowledge his many scientific contributions to dopamine studies. This work was supported in part by grants-in-aid for scientific research from the National Natural Science Foundation of China (Grant No. 31530035, 81420108015 to Zhi-Li Huang, Grant No. 31671099, 31871072 to Wei-Min Qu); the National Basic Research Program of China (Grant No. 2015CB856401 to Zhi-Li Huang); Program for Shanghai Outstanding Academic Leaders (to Zhi-Li Huang); and the Shanghai Committee of Science and Technology (Grant No. 17ZR1402000 to Yuan-Yuan Liu).
Compliance with ethical standards
Experimental protocols were approved by the Committee on the Ethics of Animal Experiments of Fudan University Shanghai Medical College and performed in accordance with ARRIVE guidelines. Every effort was made to minimize the number of animals used and any pain or discomfort experienced by the mice.
Conflict of interest
The authors declare that they have no conflicts of interest.
- Hsu B, Kin KC (1962) Pharmacological study of tetrahydropalmatine and its analogs. A new type of central depressants. Arch Int Pharmacodyn Ther 139:318–327Google Scholar
- Hu JY, Jin GZ (1999) Supraspinal D2 receptor involved in antinociception induced by l-tetrahydropalmatine. Zhongguo Yao Li Xue Bao 20:715–719Google Scholar
- Hu JY, Jin GZ (2000) Arcuate nucleus of hypothalamus involved in analgesic action of l-THP. Acta Pharmacol Sin 21:439–444Google Scholar
- Huang KX, Jin GZ (1992) The antagonistic effects of tetrahydroprotoberberines on dopamine receptors: electrophysiological studies. Sci China B 35:688–696Google Scholar
- Jin GZ, Xu J, Zhang FT, Yu LP, Li JH, Wang XL (1983) Relevance of the sedative-tranquilizing effect of l-tetrahydropalmatine to brain monoaminergic neurotransmitters. Zhongguo Yao Li Xue Bao 4:4–10Google Scholar
- Liu YY, Yin D, Chen L, Qu WM, Chen CR, Laudon M, Cheng NN, Urade Y, Huang ZL (2014) Piromelatine exerts antinociceptive effect via melatonin, opioid, and 5HT1A receptors and hypnotic effect via melatonin receptors in a mouse model of neuropathic pain. Psychopharmacology 231:3973–3985CrossRefGoogle Scholar
- Morin AK (2006) Strategies for treating chronic insomnia. Am J Manag Care 12:S230–S245Google Scholar
- Narita M, Niikura K, Nanjo-Niikura K, Furuya M, Yamashita A, Saeki M, Matsushima Y, Imai S, Shimizu T, Asato M, Kuzumaki N, Okutsu D, Miyoshi K, Suzuki M, Tsukiyama Y, Konno M, Yomiya K, Matoba M, Suzuki T (2011) Sleep disturbances in a neuropathic pain-like condition in the mouse are associated with altered GABAergic transmission in the cingulate cortex. Pain 152:1358–1372CrossRefGoogle Scholar
- Paxinos G, Franklin KBJ (2001) The mouse brain in stereotaxic coordinates. In: San Diego. Academic, Academic, San DiegoGoogle Scholar
- Takemura Y, Yamashita A, Horiuchi H, Furuya M, Yanase M, Niikura K, Imai S, Hatakeyama N, Kinoshita H, Tsukiyama Y, Senba E, Matoba M, Kuzumaki N, Yamazaki M, Suzuki T, Narita M (2011) Effects of gabapentin on brain hyperactivity related to pain and sleep disturbance under a neuropathic pain-like state using fMRI and brain wave analysis. Synapse 65:668–676CrossRefGoogle Scholar
- Xu SX, Yu LP, Han YR, Chen Y, Jin GZ (1989) Effects of tetrahydroprotoberberines on dopamine receptor subtypes in brain. Zhongguo Yao Li Xue Bao 10:104–110Google Scholar